TickerFacts.

A business in context

BIO research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-23 · 8022 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-10-20 · 0001993147-26-000004

  2. 4 · Ownership change

    Report date 2026-09-04 · 0002081681-26-000002

  3. 4 · Ownership change

    Report date 2026-09-04 · 0002024911-26-000006

  4. 4 · Ownership change

    Report date 2026-09-04 · 0002022345-26-000004

  5. 4 · Ownership change

    Report date 2026-09-04 · 0002019843-26-000004

  6. 4 · Ownership change

    Report date 2026-09-04 · 0001993147-26-000002

  7. 4 · Ownership change

    Report date 2026-09-04 · 0001924980-26-000004

  8. 4 · Ownership change

    Report date 2026-09-04 · 0001453524-26-000002

  9. 10-Q · Quarterly report

    Report date 2026-06-30 · 0000012208-26-000048

  10. 8-K · Current report

    Report date 2026-07-31 · 0000012208-26-000046 · Items 2.02,2.05,7.01,9.01

  11. 10-Q · Quarterly report

    Report date 2026-03-31 · 0000012208-26-000035

  12. 8-K · Current report

    Report date 2026-04-30 · 0000012208-26-000034 · Items 2.02,7.01,9.01

  13. 8-K · Current report

    Report date 2026-04-21 · 0000012208-26-000024 · Items 5.02,5.07,9.01

  14. DEF 14A · Proxy statement

    Report date 2026-04-21 · 0000012208-26-000020

  15. 8-K · Current report

    Report date 2026-02-19 · 0000012208-26-000012 · Items 7.01

  16. 10-K · Annual report

    Report date 2025-12-31 · 0000012208-26-000010

  17. 8-K · Current report

    Report date 2026-02-12 · 0000012208-26-000007 · Items 2.02,7.01,9.01

  18. 10-Q · Quarterly report

    Report date 2025-09-30 · 0000012208-25-000077

  19. 8-K · Current report

    Report date 2025-10-29 · 0000012208-25-000076 · Items 2.02,7.01,9.01

  20. 8-K · Current report

    Report date 2025-09-29 · 0000012208-25-000057 · Items 7.01,9.01

  21. 8-K · Current report

    Report date 2025-08-26 · 0000012208-25-000054 · Items 7.01,9.01

  22. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000012208-25-000052

  23. 8-K · Current report

    Report date 2025-07-31 · 0000012208-25-000051 · Items 2.02,7.01,9.01

  24. 8-K · Current report

    Report date 2025-07-28 · 0000012208-25-000047 · Items 5.02,8.01,9.01

  25. 8-K · Current report

    Report date 2025-06-30 · 0000012208-25-000032 · Items 8.01

  26. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000012208-25-000026

  27. 8-K · Current report

    Report date 2025-05-01 · 0000012208-25-000025 · Items 2.02,9.01

  28. 8-K · Current report

    Report date 2025-04-22 · 0000012208-25-000022 · Items 5.07

  29. DEF 14A · Proxy statement

    Report date 2025-04-22 · 0001308179-25-000235

  30. 8-K · Current report

    Report date 2025-02-21 · 0000012208-25-000009 · Items 7.01

  31. 10-K · Annual report

    Report date 2024-12-31 · 0000012208-25-000007

  32. 8-K · Current report

    Report date 2025-02-07 · 0000012208-25-000004 · Items 2.02,2.05,8.01,9.01

  33. SC 13G · Ownership disclosure

    0000869178-24-000026

  34. SC 13G/A · Ownership disclosure

    0000932471-24-000864

  35. SC 13G/A · Ownership disclosure

    0002012383-24-004110

  36. SC 13G/A · Ownership disclosure

    0000932471-24-000322

  37. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000012208-24-000063

  38. 8-K · Current report

    Report date 2024-10-30 · 0000012208-24-000062 · Items 2.02,9.01

  39. SC 13G/A · Ownership disclosure

    0000012208-24-000058

  40. SC 13G/A · Ownership disclosure

    0002012383-24-001305

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-23 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 9 transaction rows9AExercise / conversion: 45 transaction rows45MTax / exercise payment: 21 transaction rows21FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

75 matching transaction rows. Showing 51 to 75.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-05
2026-09-09
SCHWARTZ NORMAN DM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
4109.00.0
2026-09-04
2026-09-09
Mehta RajatA · Grant / award
Acquired
Restricted Stock Units
Derivative security
4601.00.0
2026-09-04
2026-09-09
ENGELHARDT EVA ANETTEA · Grant / award
Acquired
Restricted Stock Units
Derivative security
4313.00.0
2026-09-04
2026-09-09
BARRY JAMESA · Grant / award
Acquired
Restricted Stock Units
Derivative security
4313.00.0
2026-09-04
2026-09-09
ENLOE COURTNEY CA · Grant / award
Acquired
Restricted Stock Units
Derivative security
2876.00.0
2026-09-04
2026-09-09
EVRAN SEDATA · Grant / award
Acquired
Restricted Stock Units
Derivative security
4026.00.0
2026-09-04
2026-09-09
Allison SchwartzA · Grant / award
Acquired
Restricted Stock Units
Derivative security
719.00.0
2026-09-04
2026-09-09
DiVincenzo Jonathan P.A · Grant / award
Acquired
Restricted Stock Units
Derivative security
6326.00.0
2026-09-04
2026-09-09
Lakkaraju Roop KalyanA · Grant / award
Acquired
Restricted Stock Units
Derivative security
6326.00.0
2026-09-04
2026-09-09
SCHWARTZ NORMAN DA · Grant / award
Acquired
Restricted Stock Units
Derivative security
17251.00.0
2026-09-01
2026-09-03
BARRY JAMESM · Exercise / conversion
Acquired
Bio-Rad A Common Stock425.00.0
2026-09-01
2026-09-03
BARRY JAMESF · Tax / exercise payment
Disposed
Bio-Rad A Common Stock154.0380.96
2026-09-01
2026-09-03
BARRY JAMESM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
174.00.0
2026-09-01
2026-09-03
BARRY JAMESM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
251.00.0
2026-09-01
2026-09-03
Allison SchwartzF · Tax / exercise payment
Disposed
Bio-Rad A Common Stock43.0380.96
2026-09-01
2026-09-03
Allison SchwartzM · Exercise / conversion
Acquired
Bio-Rad A Common Stock117.00.0
2026-09-01
2026-09-03
Allison SchwartzM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
42.00.0
2026-09-01
2026-09-03
Allison SchwartzM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
75.00.0
2026-09-01
2026-09-03
SCHWARTZ NORMAN DM · Exercise / conversion
Acquired
Bio-Rad A Common Stock5087.00.0
2026-09-01
2026-09-03
SCHWARTZ NORMAN DF · Tax / exercise payment
Disposed
Bio-Rad A Common Stock2336.0380.96
2026-09-01
2026-09-03
SCHWARTZ NORMAN DM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
3005.00.0
2026-09-01
2026-09-03
SCHWARTZ NORMAN DM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
2082.00.0
2026-07-25
2026-07-28
ENGELHARDT EVA ANETTEF · Tax / exercise payment
Disposed
Bio-Rad A Common Stock89.0314.46
2026-07-25
2026-07-28
ENGELHARDT EVA ANETTEM · Exercise / conversion
Acquired
Bio-Rad A Common Stock246.00.0
2026-07-25
2026-07-28
ENGELHARDT EVA ANETTEM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
246.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-23 · 1658 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0000012208BIO-RAD LABORATORIES, INC.
Bio-Rad (Israel)Bio-Rad (Canada)Bio-Rad (France)Bio-Rad (United Kingdom)

Showing 4 of 4 imported Wikidata subsidiary claims. Additional aliases appear below.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
549300ZC1GPV35XYDK53
GLEIF legal name
BIO-RAD LABORATORIES, INC.
Entity / LEI registration status
ACTIVE / ISSUED
Reference data updated
2026-05-22T04:26:17Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-10-23 · 1197 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Bio-Rad Laboratories · alias · wikidata
  • Bio-Rad · alias · wikidata
  • Bio-Rad (Israel) · subsidiary · wikidata
  • Bio-Rad (Canada) · subsidiary · wikidata
  • Bio-Rad (France) · subsidiary · wikidata
  • Bio-Rad (United Kingdom) · subsidiary · wikidata
  • BIO RAD LABORATORIES INC · former SEC name · 1994-05-12 to 2018-06-18
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$2.57B$2.76B
2023-12-31$2.67B$2.95B
2022-12-31$2.80B$3.23B
2021-12-31$2.92B$3.63B
2020-12-31$2.55B$3.31B
2019-12-31$2.31B$3.05B
2018-12-31$2.29B$3.07B
2017-12-31$2.16B$2.97B

Bureau of Labor Statistics · retrieved 2026-10-23 · 9 selected series; gaps remain missing

Explore the CPI history ↗